GlyCosmos Portal

Table Filtering

Title

Authors

PubMed ID

Source

Publication Year

Text

Display
results per page.

Clear

Submissions

GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries **11001 - 11025** of **11146** in total

« First

‹ Prev

…

437

438

439

440

441

442

443

444

445

446

Next ›

Last »
Title ▲	Authors	PubMed ID	Source	Publication Year
Variants of the beta 1,3-galactosyltransferase CgtB from the bacterium Campylobacter jejuni have distinct acceptor specificities.	Bernatchez S Gilbert M Blanchard MC Karwaski MF Li J Defrees S Wakarchuk WW	17766267	Glycobiology	2007
Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones.	Bergwerff AA Stroop CJ Murray B Holtorf AP Pluschke G Van Oostrum J Kamerling JP Vliegenthart JF	7496147	Glycoconj J	1995
Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex.	Khoo KH Tang JB Chatterjee D	11073941	J Biol Chem	2001
Variation of acharan sulfate and monosaccharide composition and analysis of neutral N-glycans in African giant snail (Achatina fulica).	Park Y Zhang Z Laremore TN Li B Sim JS Im AR Ahn MY Kim YS Linhardt RJ	18670878	Glycoconj J	2008
Variations in the chondroitin sulfate-protein linkage region of aggrecans from bovine nasal and human articular cartilages.	Cheng F Heinegârd D Fransson L Bayliss M Bielicki J Hopwood J Yoshida K	8910487	J Biol Chem	1996
Variations of pH as an additional tool in the analysis of crowded NMR spectra of fucosylated chondroitin sulfates.	Ustyuzhanina NE Dmitrenok AS Bilan MI Shashkov AS Gerbst AG Usov AI Nifantiev NE	26895544	Carbohydr Res	2016
Various stages of schistosoma express Lewis(x), LacdiNAc, GalNAcbeta1-4 (Fucalpha1-3)GlcNAc and GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAc carbohydrate epitopes: detection with monoclonal antibodies that are characterized by enzymatically synthesized neoglycoproteins.	van Remoortere A Hokke CH van Dam GJ van Die I Deelder AM van den Eijnden DH	10814702	Glycobiology	2000
Various sulfated carbohydrate tumor marker candidates identified by focused glycomic analyses.	Tanaka-Okamoto M Mukai M Takahashi H Fujiwara Y Ohue M Miyamoto Y	28025252	Glycobiology	2017
Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.	Soker S Svahn CM Neufeld G	7681826	J Biol Chem	1993
Verification of biochemical activity for proteins nanografted on gold surfaces.	Staii C Wood DW Scoles G	18081283	J Am Chem Soc	2008
Versatile fluorescent derivatization of glycans for glycomic analysis.	Xia B Kawar ZS Ju T Alvarez RA Sachdev GP Cummings RD	16278655	Nat Methods	2005
Versatile synthesis of bi- and tri-antennary galactose ligands: interaction with the Gal/GalNAc receptor of human hepatoma cells.	Kichler A Schuber F	7496142	Glycoconj J	1995
Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity.	Yang W Yee AJ	24594381	Biochim Biophys Acta	2014
Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.	Akinfenwa PY Bond WS Ildefonso CJ Hurwitz MY Hurwitz RL	28684419	J Biol Chem	2017
Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1.	Zheng PS Reis M Sparling C Lee DY La Pierre DP Wong CK Deng Z Kahai S Wen J Yang BB	16431924	J Biol Chem	2006
Versican V0 and V1 guide migratory neural crest cells.	Dutt S Kléber M Matasci M Sommer L Zimmermann DR	16510447	J Biol Chem	2006
Versican facilitates chondrocyte differentiation and regulates joint morphogenesis.	Choocheep K Hatano S Takagi H Watanabe H Kimata K Kongtawelert P Watanabe H	20404343	J Biol Chem	2010
Versican in inflammation and tissue remodeling: the impact on lung disorders.	Andersson-Sjöland A Hallgren O Rolandsson S Weitoft M Tykesson E Larsson-Callerfelt AK Rydell-Törmänen K Bjermer L Malmström A Karlsson JC Westergren-Thorsson G	25371494	Glycobiology	2015
Versican interacts with chemokines and modulates cellular responses.	Hirose J Kawashima H Yoshie O Tashiro K Miyasaka M	11083865	J Biol Chem	2001
Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination.	Ghorbani S Jelinek E Jain R Buehner B Li C Lozinski BM Sarkar S Kaushik DK Dong Y Wight TN Karimi-Abdolrezaee S Schenk GJ Strijbis EM Geurts J Zhang P Ling CC Yong VW	35508608	Nat Commun	2022
Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts.	Suwan K Choocheep K Hatano S Kongtawelert P Kimata K Watanabe H	19164294	J Biol Chem	2009
Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development.	Hatano S Kimata K Hiraiwa N Kusakabe M Isogai Z Adachi E Shinomura T Watanabe H	22692047	Glycobiology	2012
Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation.	Kamiya N Watanabe H Habuchi H Takagi H Shinomura T Shimizu K Kimata K	16257955	J Biol Chem	2006
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine.	Roquemore EP Dell A Morris HR Panico M Reason AJ Savoy LA Wistow GJ Zigler JS Jr Earles BJ Hart GW	1730617	J Biol Chem	1992
Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine.	Crowther RS Roomi NW Fahim RE Forstner JF	3297167	Biochim Biophys Acta	1987

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

LM-GlycoRepo

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements